"fezakinumab" meaning in English

See fezakinumab in All languages combined, or Wiktionary

Noun

Etymology: From -kin- (“interleukin”) + -umab (“human monoclonal antibody”). Etymology templates: {{af|en|-kin-|-umab|t1=interleukin|t2=human monoclonal antibody}} -kin- (“interleukin”) + -umab (“human monoclonal antibody”) Head templates: {{en-noun|-}} fezakinumab (uncountable)
  1. (pharmacology) A human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis. Wikipedia link: fezakinumab Tags: uncountable Categories (topical): Pharmaceutical drugs
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-kin-",
        "3": "-umab",
        "t1": "interleukin",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-kin- (“interleukin”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "fezakinumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -kin-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis."
      ],
      "id": "en-fezakinumab-en-noun--6D~83k2",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "interleukin",
          "interleukin"
        ],
        [
          "psoriasis",
          "psoriasis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "fezakinumab"
      ]
    }
  ],
  "word": "fezakinumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-kin-",
        "3": "-umab",
        "t1": "interleukin",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-kin- (“interleukin”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "fezakinumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -kin-",
        "English terms suffixed with -umab",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "interleukin",
          "interleukin"
        ],
        [
          "psoriasis",
          "psoriasis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "fezakinumab"
      ]
    }
  ],
  "word": "fezakinumab"
}

Download raw JSONL data for fezakinumab meaning in English (1.4kB)


This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-12-15 from the enwiktionary dump dated 2024-12-04 using wiktextract (8a39820 and 4401a4c). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.